About the Product

Tofihike is generally well tolerated. Mild side effects can include headache, dizziness, gastrointestinal upset, dry mouth, or mild fatigue. Unlike typical benzodiazepines, it has a lower risk of sedation, dependence, and withdrawal symptoms, but prolonged use should still be monitored. Rarely, allergic reactions, palpitations, or sleep disturbances may occur.

Tofihike 100 Tablet is indicated for the management of anxiety disorders, including generalized anxiety disorder (GAD), psychosomatic disorders with anxiety, and stress-related autonomic dysfunction. It may be used as adjunctive therapy in depression with anxiety and in conditions where maintaining alertness and motor coordination is important.

Tofihike 100 Tablet should only be taken under medical supervision. It is not intended for long-term self-medication due to the risk, albeit lower, of dependence. Caution is advised in patients with liver or kidney impairment, elderly individuals, and those with a history of substance abuse. It is not recommended during pregnancy and breastfeeding unless the potential benefits outweigh the risks. Avoid alcohol and other CNS depressants as they may potentiate sedative effects. Do not abruptly discontinue without medical advice, as gradual tapering may be necessary after prolonged use.

Store Tofihike 100 Tablet in a cool, dry place below 30°C, away from direct sunlight and moisture. Keep it in the original blister packaging and out of reach of children. Do not use beyond the expiry date printed on the pack.